<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="research-article" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Russian Journal of Allergy</journal-id><journal-title-group><journal-title xml:lang="en">Russian Journal of Allergy</journal-title><trans-title-group xml:lang="ru"><trans-title>Российский Аллергологический Журнал</trans-title></trans-title-group></journal-title-group><issn publication-format="print">1810-8830</issn><issn publication-format="electronic">2686-682X</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">325</article-id><article-id pub-id-type="doi">10.36691/RJA325</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>Articles</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>Статьи</subject></subj-group><subj-group subj-group-type="article-type"><subject>Research Article</subject></subj-group></article-categories><title-group><article-title xml:lang="en">Crossreactive allergen-specific IgE in children with birch pollen allergic rhinitis</article-title><trans-title-group xml:lang="ru"><trans-title>Перекрестно-реагирующие аллерген-специфические IgE у детей с вызванным пыльцой березы аллергическим ринитом</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Samoylikov</surname><given-names>P V</given-names></name><name xml:lang="ru"><surname>Самойликов</surname><given-names>Павел Владимирович</given-names></name></name-alternatives><email>samoilikov@mail.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Mazurina</surname><given-names>S A</given-names></name><name xml:lang="ru"><surname>Мазурина</surname><given-names>С А</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gushchin</surname><given-names>P I</given-names></name><name xml:lang="ru"><surname>Гущин</surname><given-names>П И</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><name-alternatives><name xml:lang="en"><surname>Gervazieva</surname><given-names>V B</given-names></name><name xml:lang="ru"><surname>Гервазиева</surname><given-names>В Б</given-names></name></name-alternatives><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Mechnikov's Research Institute of Vaccines and Sera</institution></aff><aff><institution xml:lang="ru">ФГБНУ НИИ вакцин и сывороток им. И.И. Мечникова</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2017-04-15" publication-format="electronic"><day>15</day><month>04</month><year>2017</year></pub-date><volume>14</volume><issue>2</issue><issue-title xml:lang="en">VOL 14, NO2 (2017)</issue-title><issue-title xml:lang="ru">ТОМ 14, №2 (2017)</issue-title><fpage>66</fpage><lpage>70</lpage><history><date date-type="received" iso-8601-date="2020-03-10"><day>10</day><month>03</month><year>2020</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2017, Pharmarus Print Media</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2017, Фармарус Принт Медиа</copyright-statement><copyright-year>2017</copyright-year><copyright-holder xml:lang="en">Pharmarus Print Media</copyright-holder><copyright-holder xml:lang="ru">Фармарус Принт Медиа</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/" start_date="2019-12-15"/></permissions><self-uri xlink:href="https://rusalljournal.ru/raj/article/view/325">https://rusalljournal.ru/raj/article/view/325</self-uri><abstract xml:lang="en"><p>Objective. The aim of this study was to research a sIgE allergen profile of birch pollen and to evaluate a contribution of some homologous food allergens as well as latex allergen to the development of sensibility in allergic rhinitis (AR) / rhinoconjunctivitis patients, in focus of cross-reactivity and oral allergy syndrome.. Methods. Blood sera of 21 AR/rhinoconjunctivitis patients (at the age of 3 to 16) and 20 healthy persons without allergy symptoms were used. sIgE to birch pollen, soybean, latex, apple and celery as well as the total IgE levels were measured by the ImmunoCAP method (Phadia, Sweden) and the ELISA kits (Alkorbio, Russia). Results. We detected high total IgE levels, sIgE to allergens of birch pollen, apple, celery, as well as to recombinant allergens of birch Bet v 1, Bet v 2 and soybean - Gly m 4 in AR patients. Correlation analysis of IgE humoral response to homologous proteins showed the direct valid dependence between the sIgE levels to birch isoallergen Bet v 1 and soy isoallergen Gly m 4 (r=0,84; p&lt;0,05). There was also the direct valid correlation between the sIgE levels to birch isoallergen Bet v 1 and allergens of apple and celery (r=0,67 and 0,57, accordingly). Conclusion. Correlation between the IgE humoral antibody response to the major allergen of birch pollen Bet v 1 on the one hand and allergens of soy, apple and celery on the other hand shows that cross-reactivity can play an important role in exacerbation of clinical symptoms in AR/rhinoconjunctivitis patients including oral allergy syndrome.</p></abstract><trans-abstract xml:lang="ru"><p>Цель работы. Исследовать IgE-связывающий аллергенный профиль пыльцы березы и оценить возможный вклад гомологичных аллергену пыльцы березы некоторых пищевых аллергенов, а также аллергена латекса в развитие сенсибилизации больных аллергическим ринитом (АР) / риноконъюнктивитом, что обосновано важностью проблемы АР и связанного с ним синдрома оральной аллергии, вызванных перекрестными реакциями. Материалы и методы. Использованы сыворотки крови 21 больного (в возрасте от 3 до 16 лет) АР/риноконъюнктивитом и 20 здоровых лиц без симптомов аллергии. Аллерген-специфический IgE (асIgЕ) к аллергенам пыльцы березы, сои, яблоку, сельдерею и латексу, а также уровень общего IgE определяли методом ImmunoCap (Phadia, Швейцария) и с использованием тест-систем Алкорбио (Россия). Результаты. Выявлен повышенный уровень общего IgE и асIgE к аллергенам пыльцы березы, яблока, сельдерея, а также рекомбинантным аллергенам березы (Bet v 1, Bet v 2) и сои (Gly m 4) у обследованных больных. Корреляционный анализ IgE-обусловленного гуморального ответа к гомологичным белкам показал прямую достоверную взаимосвязь между уровнем асIgE к изоаллергену березы Bet v 1 и изоаллергену сои Gly m 4 (r=0,84; p&lt;0,05). Показана также достоверная прямая корреляция между асIgE к Bet v 1 и асIgE к аллергенам яблока и сельдерея, которая составила 0,67 и 0,57 соответственно (p&lt;0,05). Заключение. Выявленная взаимосвязь между IgE-обусловленным гуморальным иммунным ответом к главному аллергену березы Bet v 1, с одной стороны, и аллергенам сои, яблока и сельдерея - с другой, свидетельствует о том, что перекрестная реактивность испытанных аллергенов может быть потенциальным фактором обострения клинических симптомов у больных АР/риноконъюнктивитом, в том числе орального аллергического синдрома.</p></trans-abstract><kwd-group xml:lang="en"><kwd>Bet v 2</kwd><kwd>Gly m 4</kwd><kwd>allergic rhinitis</kwd><kwd>sIgE to Bet v 1</kwd><kwd>Bet v 2</kwd><kwd>Gly m 4</kwd><kwd>food allergens</kwd><kwd>latex</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>аллергический ринит</kwd><kwd>аллерген-специфический IgE к Bet v 1</kwd><kwd>пищевые аллергены</kwd><kwd>латекс</kwd></kwd-group></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><mixed-citation>D’Amato G., Spieksma F.T., Liccardi G. et al. Pollen-related allergy in Europe. Allergy. 1998, v. 53, p. 567-578.</mixed-citation></ref><ref id="B2"><label>2.</label><mixed-citation>Papadopoulos N.G., Agache I., Bavbek S. et al. Research needs in allergy: an EAACI position paper, in collaboration with EFA. Clinical and Translational Allergy. 2012, v. 2, p. 21.</mixed-citation></ref><ref id="B3"><label>3.</label><mixed-citation>Asher M.I., Montefort S., Bjorksten B. et al. Worldwide time trends in the prevalence of symptoms of asthma, allergic rhinoconjunctivitis, and eczema in childhood: ISAAC Phases One and Three repeat multicountry cross-sectional surveys. Lancet. 2006, v. 368, p. 733-743.</mixed-citation></ref><ref id="B4"><label>4.</label><mixed-citation>Аллергический ринит у детей: пособие для врачей. М., 2002, с. 68-70.</mixed-citation></ref><ref id="B5"><label>5.</label><mixed-citation>Ильина Н.И. Аллергический ринит. Consilium medicum. 2000, № 2, с. 338-344.</mixed-citation></ref><ref id="B6"><label>6.</label><mixed-citation>Sinha M., Prabha Singh R., Kushwaha Singh G. et al. Current overview of allergens of plant pathogenesis related protein families. The Scientific World Journal. 2014, Article ID 543195,19 pages http://dx.doi.org/10.1155/2014/543195.</mixed-citation></ref><ref id="B7"><label>7.</label><mixed-citation>Kleine T.J., Vogel L., Crowel D.N. et al. Severe oral allergy syndrome and anaphylactic reactions caused by a Bet v 1 related PR 10 protein in soybean, SAM22. J. Allergy Clin. Immunol. 2002, v. 10, p. 797-804.</mixed-citation></ref><ref id="B8"><label>8.</label><mixed-citation>Mittag D., Vieths S., Vogel L. et al. Soybean allergy in patients allergic to birch pollen: Clinical investigation and molecular characterization of allergens. J. Allergy Clin. Immunol. 2004, v. 113, p. 148-54.</mixed-citation></ref><ref id="B9"><label>9.</label><mixed-citation>Vanek-Krebitz M., Hoffmann-Sommergruber K., Laimer da Camara Machado M. et al. Cloning and sequencing of Mal d 1, the major allergen from apple (Malus domestica), and its immunological relationship to Bet v 1, the major birch pollen allergen. Biochem. Biophys. Res. Commun. 1995, v. 214, p. 538-551.</mixed-citation></ref><ref id="B10"><label>10.</label><mixed-citation>Schmitz-Eiberger M., Matthes A. Effect of harvest maturity, duration of storage and shelf life of apples on the allergen Mal d 1, polyphenoloxidase activity and polyphenol content. Food Chem. 2011, v. 127, p. 1459-1464.</mixed-citation></ref><ref id="B11"><label>11.</label><mixed-citation>Matthes A., Schmitz-Eiberger M. Apple (Malus domestica L. Borkh.) allergen Mal d 1: effect of cultivar, cultivation system, and storage conditions. J. Agric. Food Chem. 2009, v. 57, p. 10548-10553.</mixed-citation></ref><ref id="B12"><label>12.</label><mixed-citation>Geroldinger-Simic M., Zelniker T., Aberer W. et al. Birch pollen-related food allergy: clinical aspects and the role of allergen-specific IgE and IgG4 antibodies. J. Allergy Clin. Immunol. 2011, v. 127, p. 616-622.</mixed-citation></ref><ref id="B13"><label>13.</label><mixed-citation>Burney P.G., Potts J., Kummeling I. et al. The prevalence and distribution of food sensitization in European adults. Allergy. 2014, v. 69, p. 365-371.</mixed-citation></ref><ref id="B14"><label>14.</label><mixed-citation>Ballmer-Weber B.K., Vieths S., Lüttkopf D. et al. Celery allergy confirmed by double-blind, placebo-controlled food challenge: a clinical study in 32 subjects with a history of adverse reactions to celery root. J. Allergy Clin. Immunol. 2000, v. 106, p. 373-378.</mixed-citation></ref><ref id="B15"><label>15.</label><mixed-citation>Hoffmann-Sommergruber K., Demoly P., Crameri R. et al. IgE reactivity to Api g 1, a major celery allergen, in a Central European population is based on primary sensitization by Bet v 1. J. Allergy Clin. Immunol. 1999, v. 104, p. 478-484.</mixed-citation></ref><ref id="B16"><label>16.</label><mixed-citation>Breiteneder H., Hoffmann-Sommergruber K., O’Riordain G. et al. Molecular characterization of Api g 1, the major allergen of celery (Apium graveolens), and its immunological and structural relationships to a group of 17-kDa tree pollen allergens. Eur. J. Biochem. 1995, v. 233, p. 484-489.</mixed-citation></ref><ref id="B17"><label>17.</label><mixed-citation>Hoffmann-Sommergruber K., O’Riordain G., Ahorn H. et al. Molecular characterization of Dau c 1, the Bet v 1 homologous protein from carrot and its cross-reactivity with Bet v 1 and Api g 1. Clin. Exp. Allergy. 1999, v. 29, p. 840-847.</mixed-citation></ref><ref id="B18"><label>18.</label><mixed-citation>Schirmer T., Hoffimann-Sommergrube K., Susani M. et al. Crystal structure of the major celery allergen Api g 1: molecular analysis of cross-reactivity. J. Mol. Biol. 2005, v 351, p. 1101-1109.</mixed-citation></ref><ref id="B19"><label>19.</label><mixed-citation>Movérare R., Westritschnig K., Svensson M. et al. Different IgE reactivity profiles in birch pollen-sensitive patients from six European populations revealed by recombinant allergens: An imprint of local sensitization. Arch. Allergy Immunol. 2002, v. 128, p. 325-335.</mixed-citation></ref><ref id="B20"><label>20.</label><mixed-citation>Hamilton R.G., MacGlashan D.W. Jr, Saini S.S. IgE antibody-specific activity in human allergic disease. Immunol. Res. 2010, v. 47, p. 273-284.</mixed-citation></ref><ref id="B21"><label>21.</label><mixed-citation>De Swert L.F., Gadisseur R., Sjölander S. et al. Secondary soy allergy in children with birch pollen allergy may cause both chronic and acute symptoms. Pediatr. Allergy Immunol. 2012, v. 23, p. 117-123.</mixed-citation></ref></ref-list></back></article>
